JIUYUAN GENE (02566) repurchased approximately 26,000 shares at a cost of approximately HK$255,000 on February 12th.
Nine Rivers Genetic (02566) announced the repurchase of 26,000 shares at a cost of approximately HK$255,000 on February 12, 2026.
JIUYUAN GENE (02566) announced that it will spend approximately HK $255,000 to repurchase 26,000 shares on February 12, 2026.
Related Articles
Biocytogen Pharmaceuticals-B(02315): Liu Hongkang appointed as non-executive director.
CMON (01792) completed the placement of a total of 10.32 million shares, raising a net of approximately 9.4 million Hong Kong dollars.
LIANLIAN (02598) spent HK$86,000 on February 12 to repurchase 12,500 shares.
Biocytogen Pharmaceuticals-B(02315): Liu Hongkang appointed as non-executive director.
CMON (01792) completed the placement of a total of 10.32 million shares, raising a net of approximately 9.4 million Hong Kong dollars.
LIANLIAN (02598) spent HK$86,000 on February 12 to repurchase 12,500 shares.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
